Skip to content
Lisa A. Beck, M.D.

Lisa A. Beck, M.D.

Dermatology

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Appointment (585) 275-7546

Locations

About Me

Dr. Beck brings more than 20 years' experience to the treatment of atopic dermatitis and eczema. She is currently involved in an NIH-funded study to determine why certain patients are susceptible to the herpes simplex and Staphylococcus aureus viruses. Dr. Beck received her undergraduate degree fr...
Dr. Beck brings more than 20 years' experience to the treatment of atopic dermatitis and eczema. She is currently involved in an NIH-funded study to determine why certain patients are susceptible to the herpes simplex and Staphylococcus aureus viruses. Dr. Beck received her undergraduate degree from Mount Holyoke College and her medical degree from the State University of New York at Stony Brook.

Certified Specialties

Dermatology - American Board of Dermatology

Faculty Appointments

Professor - Department of Dermatology (SMD)

Lowell A. and Carol A. Goldsmith Professor in Dermatology - Department of Dermatology (SMD)

Professor - Department of Medicine, Allergy/Immunology and Rheumatology (SMD) - Joint

Professor - Department of Pathology and Laboratory Medicine (SMD) - Joint

Credentials

Residency & Fellowship

Fellowship, Research, Johns Hopkins Hospital. 1992 - 1994

Residency, Dermatology, Duke University Medical Center. 1987 - 1990

Residency, Internal Medicine, University of Rochester Medical Center. 1986 - 1987

Internship, Internal Medicine, University of Rochester Medical Center. 1985 - 1986

Education

MD | Stony Brook University Hospital (USA). 1985

Awards

Dermatology Faculty Teaching Award. 2008

Mentor for NEASE Skin Research Grant Recipient. 2007

Mentor for AAAAI Summer Research Grant Recipient. 2007

Mentor for Astellas Skin Research Grant Recipient. 2006

Mentor for Fujisawa AAAAI Research Grant Recipient. 2005

Mentor for Howard Hughes Summer Fellowship Recipient. 1997

Physician-Scientist Award. 1994

Research Award. 1994

Teaching Appreciation Award. 1992

Internal Medicine Teaching Award. 1992

Research

Dr. Lisa Beck has dedicated her 25 year career to finding safe, effective treatments for patients with atopic dermatitis, more commonly known as eczema. Internationally recognized as an eczema expert, her research was instrumental in the development of the first biologic drug called dupilumab (brand...
Dr. Lisa Beck has dedicated her 25 year career to finding safe, effective treatments for patients with atopic dermatitis, more commonly known as eczema. Internationally recognized as an eczema expert, her research was instrumental in the development of the first biologic drug called dupilumab (brand name Dupixent) for the treatment of adults with moderate to severe eczema. She was the lead author of a 2014 New England Journal of Medicine paper that set the stage for the FDA approval of this drug in March 2017. She is Co-Director of the URMC Center for Allergic Disease Research (CADR) which was recently chosen as one of four US centers with the World Allergy Organizations Center of Excellence designation. She has been the secretary of the International Eczema Council (IEC) since its inception in 2014, emeritus member of the National Eczema Association (NEA) Scientific Advisory committee, and President-Elect of the Society of Investigative Dermatology. She has been NIH-funded to study this disease since 1992 and her main focus is now on understanding why certain eczema patients are susceptible to cutaneous viral infections such as herpes simplex as well as bacterial colonization or infection with Staphylococcus aureus. As the founding director of the URMC Dermatology Clinical Trials Unit, she has completed >14 clinical AD registry, mechanistic, and interventional trials, all of which met or exceeded enrollment/retention expectations and has > 500 person URMC AD patient Registry. She has had continuous NIH funding since 1994, and has been co-PI of the NIH/NIAID-funded Atopic Dermatitis Research Network (ADRN) since it inception in 2004, which has amassed the largest cross-sectional registry of deeply phenotyped AD subjects in the world. She has been PI of the ADRN Biomarker Repository since 2014 with >150,000 serum and skin swab samples. Dr. Beck received her undergraduate degree from Mount Holyoke College, her medical degree from the State University of New York at Stony Brook, two years of internal medicine training at Strong Memorial Hospital, Dermatology residency at Duke University and an Immunology Research fellowship at Johns Hopkins University.

Research Lab

Clinical Trials

Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis (ADRN-12)

Lead Researcher: Lisa A Beck

This is a study which will characterize the gene expression profiles that underlie mild and moderate-severe Atopic dermatitis (AD). It will determine changes in these expression patterns in response to standard-of-care treatment....

Longitudinal "Real-World" Changes in Skin Microbial Ecology in AD Patients

Lead Researcher: Lisa A Beck

Everybody's skin has bacteria that normally lives on it. Previous research has shown that people with eczema have higher concentrations of a certain bacteria (S. aureus), especially when their disease is active. The purpose of this study is (a) to se...

Patents

System and Method for Studying Epidermis Samples Ex Vivo

Issue date: March 31, 2015

Patent #: 8,993,257

Country: United States

Inventors: Lisa A Beck, Anna De Benedetto

Designed Peptides for Tight Junction Barrier Modulation

Issue date: June 02, 2020

Patent #: ZL 201480052086.0

Country: China, People's Republic of

Inventors: Elizabeth A Anderson, Lisa A Beck, Anna De Benedetto, Benjamin Locke Miller

Designed Peptides for Tight Junction Barrier Modulation

Issue date: March 24, 2021

Patent #: 3033108

Country: Europe

Inventors: Elizabeth A Anderson, Lisa A Beck, Anna De Benedetto, Benjamin Locke Miller

Designed Peptides for Tight Junction Barrier Modulation

Issue date: September 12, 2017

Patent #: 9,757,428

Country: United States

Inventors: Elizabeth A Anderson, Lisa A Beck, Anna De Benedetto, Benjamin Locke Miller

Designed Peptides for Tight Junction Barrier Modulation

Issue date: March 24, 2021

Patent #: FR3033108

Country: France

Inventors: Elizabeth A Anderson, Lisa A Beck, Anna De Benedetto, Benjamin Locke Miller

Designed Peptides for Tight Junction Barrier Modulation

Issue date: March 24, 2021

Patent #: DE3033108

Country: Germany

Inventors: Elizabeth A Anderson, Lisa A Beck, Anna De Benedetto, Benjamin Locke Miller

Designed Peptides for Tight Junction Barrier Modulation

Issue date: March 24, 2021

Patent #: IT3033108

Country: Italy

Inventors: Elizabeth A Anderson, Lisa A Beck, Anna De Benedetto, Benjamin Locke Miller

Designed Peptides for Tight Junction Barrier Modulation

Issue date: March 24, 2021

Patent #: ES3033108

Country: Spain

Inventors: Elizabeth A Anderson, Lisa A Beck, Anna De Benedetto, Benjamin Locke Miller

Designed Peptides for Tight Junction Barrier Modulation

Issue date: March 24, 2021

Patent #: GB3033108

Country: United Kingdom

Inventors: Elizabeth A Anderson, Lisa A Beck, Anna De Benedetto, Benjamin Locke Miller

Publications

Journal Articles

Improved patient- and caregiver-reported outcomes distinguish tacrolimus 0.03% from crisaborole in children with atopic dermatitis.

Ryan Wolf J, Chen A, Wieser J, Johnson B, Baughman L, Lee G, Pope E, Franco A, Love T, Beck LA

Journal of the European Academy of Dermatology and Venereology : JEADV.. 2024 February 15 Epub 02/15/2024.

The vIGA-AD scale for atopic dermatitis: uptake in the past five years and position of the International Eczema Council.

Bissonnette R, Simpson E, Eichenfield LF, Guttman-Yassky E, Silverberg JI, Beck LA, Mija L, Thyssen JP, Bieber T, Kabashima K, Siegfried E, Stingl G, van de Kerkhof P, Yosipovitch G, Paul C, Paller AS

Journal of the European Academy of Dermatology and Venereology : JEADV.. 2023 November 9 Epub 11/09/2023.

Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial.

Guttman-Yassky E, Bahadori L, Brooks L, Clark KL, Grindebacke H, Ho CN, Katial R, Pham TH, Walton C, Datto CJ,

Journal of the European Academy of Dermatology and Venereology : JEADV.. 2023 October 37 (10):e1211-e1214. Epub 06/12/2023.

Bleach baths enhance skin barrier, reduce itch but do not normalize skin dysbiosis in atopic dermatitis.

Stolarczyk A, Perez-Nazario N, Knowlden SA, Chinchilli E, Grier A, Paller A, Gill SR, De Benedetto A, Yoshida T, Beck LA

Archives of dermatological research.. 2023 September 27 Epub 09/27/2023.

virulence factors decrease epithelial barrier function and increase susceptibility to viral infection.

Moran MC, Brewer MG, Schlievert PM, Beck LA

Microbiology spectrum.. 2023 September 22 :e0168423. Epub 09/22/2023.

History of S. aureus Skin Infection Significantly Associates with History of Eczema Herpeticum in Patients with Atopic Dermatitis.

Moran MC, Klose A, Yoshida T, De Benedetto A, Schneider LC, Ong PY, Simpson EL, Leung DYM, Miller BL, Seplaki CL, Beck LA

Dermatology and therapy.. 2023 August 24 Epub 08/24/2023.

Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: results from a phase 2b, randomized, controlled trial.

Guttman-Yassky E, Silverberg JI, Thaçi D, Papp KA, Ständer S, Beck LA, Kim BS, Hu X, Liu J, Calimlim BM, Vigna N, Crowley JT, Teixeira HD, Thyssen JP

Journal of the European Academy of Dermatology and Venereology : JEADV.. 2023 August 1 Epub 08/01/2023.

Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study.

Reich K, Silverberg JI, Papp KA, Deleuran M, Katoh N, Strober B, Beck LA, de Bruin-Weller M, Werfel T, Zhang F, Biswas P, DiBonaventura MD, Chan G, Johnson S, Farooqui SA, Kerkmann U, Clibborn C

Journal of the European Academy of Dermatology and Venereology : JEADV.. 2023 June 19 Epub 06/19/2023.

Abrocitinib effect on patient-reported outcomes in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study.

Reich K, Silverberg JI, Papp KA, Deleuran M, Katoh N, Strober B, Beck LA, de Bruin-Weller M, Werfel T, Zhang F, Biswas P, DiBonaventura MD, Chan G, Farooqui SA, Kerkmann U, Clibborn C

Journal of the European Academy of Dermatology and Venereology : JEADV.. 2023 June 15 Epub 06/15/2023.

Rapid Reduction in Staphylococcus aureus in Atopic Dermatitis Subjects Following Dupilumab Treatment.

Simpson EL, Schlievert PM, Yoshida T, Lussier S, Boguniewicz M, Hata T, Fuxench Z, De Benedetto A, Ong PY, Ko J, Calatroni A, Rudman Spergel AK, Plaut M, Quataert SA, Kilgore SH, Peterson L, Gill AL, David G, Mosmann T, Gill SR, Leung DYM, Beck LA

The Journal of allergy and clinical immunology.. 2023 June 12 Epub 06/12/2023.

JAK Signaling Is Critically Important in Cytokine-Induced Viral Susceptibility of Keratinocytes.

Arnold KA, Peterson LF, Beck LA, Brewer MG

International journal of molecular sciences.. 2023 May 2524 (11)Epub 05/25/2023.

Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity from the ADRN Registry.

Simpson EL, De Benedetto A, Boguniewicz M, Ong PY, Lussier S, Villarreal M, Schneider LC, Paller AS, Guttman-Yassky E, Hanifin JM, Spergel JM, Barnes KC, David G, Austin B, Leung DYM, Beck LA

The journal of allergy and clinical immunology. In practice.. 2023 May 12 Epub 05/12/2023.

Stage of Keratinocyte Differentiation is a Key Determinant of Viral Susceptibility in Human Skin.

Moran MC, Chinchilli E, Kenney HM, Pope EM, Scott G, Brewer MG, Beck LA

The Journal of investigative dermatology.. 2023 March 28 Epub 03/28/2023.

Developing integrated care pathways for atopic dermatitis-Challenges and unmet needs.

Zuberbier T, Beck LA, Bedbrook A, de Bruin-Weller M, Bousquet J, Cork M, Douladiris N, Katoh N, Mortz CG, Werfel T, Wojciech F, Wollenberg A, Siemens K, Stevanovic K, Worm M,

Clinical and translational allergy.. 2023 March 13 (3):e12236. Epub 1900 01 01.

Erythema Multiforme Secondary to Poison Ivy Contact Dermatitis.

Smith HD, Williams B, Beck LA, De Benedetto A

Dermatitis : contact, atopic, occupational, drug.. 2023 February 27 Epub 02/27/2023.

Management of Allergic Skin Disorders in Pregnancy.

Pope EM, Laageide L, Beck LA

Immunology and allergy clinics of North America.. 2023 February 43 (1):117-132. Epub 10/28/2022.

The IL-4R? Q576R polymorphism is associated with increased severity of atopic dermatitis and exaggerates allergic skin inflammation in mice.

Yang B, Wilkie H, Das M, Timilshina M, Bainter W, Woods B, Daya M, Boorgula MP, Mathias RA, Lai P, Petty CR, Weller E, Harb H, Leung DYM, Beck LA, Simpson EL, Hata TR, Barnes KC, Phipatanakul W, Leyva-Castillo JM, Geha RS

The Journal of allergy and clinical immunology.. 2023 January 20 Epub 01/20/2023.

Host Cationic Antimicrobial Molecules Inhibit S. aureus Exotoxin Production.

Schlievert PM, Kilgore SH, Beck LA, Yoshida T, Klingelhutz AJ, Leung DYM

mSphere.. 2023 January 4 :e0057622. Epub 01/04/2023.

IgE Sensitization Drives the Atopic March.

Beck LA, Pesonen M, Thakar J, Georas SN, Järvinen KM

American journal of respiratory and critical care medicine.. 2022 December 8 Epub 12/08/2022.

Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: analysis of microbial diversity in ECZTRA 1, a randomized controlled trial.

Beck LA, Bieber T, Weidinger S, Tauber M, Saeki H, Irvine AD, Eichenfield LF, Werfel T, Arlert P, Jiang L, Røpke M, Paller AS

Journal of the American Academy of Dermatology.. 2022 December 3 Epub 12/03/2022.

Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis.

Beck LA, Cork MJ, Amagai M, De Benedetto A, Kabashima K, Hamilton JD, Rossi AB

JID innovations : skin science from molecules to population health.. 2022 September 2 (5):100131. Epub 04/26/2022.

Supply Chain Disruptions During COVID Pandemic Uncover Differences in Keratinocyte Culture Media.

Moran MC, Pope EM, Brewer MG, Beck LA

JID innovations : skin science from molecules to population health.. 2022 August 22 :100151. Epub 08/22/2022.

Bleach baths for atopic dermatitis: Evidence of efficacy but more data are needed.

Paller AS, Beck LA

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.. 2022 June 128 (6):617-618. Epub 1900 01 01.

Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.

Beck LA, Deleuran M, Bissonnette R, de Bruin-Weller M, Galus R, Nakahara T, Seo SJ, Khokhar FA, Vakil J, Xiao J, Marco AR, Levit NA, O'Malley JT, Shabbir A

American journal of clinical dermatology.. 2022 May 3 Epub 05/03/2022.

Conditions That Simulate the Environment of Atopic Dermatitis Enhance Susceptibility of Human Keratinocytes to Vaccinia Virus.

Brewer MG, Monticelli SR, Moran MC, Miller BL, Beck LA, Ward BM

Cells.. 2022 April 1411 (8)Epub 04/14/2022.

Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data.

Paller AS, Beck LA, Blauvelt A, Siegfried EC, Cork MJ, Wollenberg A, Chen Z, Khokhar FA, Vakil J, Zhang A, Bansal A, Cyr SL

Pediatric dermatology.. 2022 January 26 Epub 01/26/2022.

IL-17-Dependent Dysregulated Cutaneous Immune Homeostasis in the Absence of the Wiskott-Aldrich Syndrome Protein.

Herman KE, Yoshida T, Hughson A, Grier A, Gill SR, Beck LA, Fowell DJ

Frontiers in immunology.. 2022 13 :817427. Epub 02/21/2022.

Skin barrier defects in atopic dermatitis: From old idea to new opportunity.

Yoshida T, Beck LA, De Benedetto A

Allergology international : official journal of the Japanese Society of Allergology.. 2021 December 13 Epub 12/13/2021.

Novel systemic treatments in atopic dermatitis: Are there sex differences?

Tuttle KL, Forman J, Beck LA

International journal of women's dermatology.. 2021 December 7 (5Part A):606-614. Epub 10/12/2021.

Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trials.

Wollenberg A, Beck LA, de Bruin Weller M, Simpson EL, Imafuku S, Boguniewicz M, Zachariae R, Olsen CK, Thyssen JP

The British journal of dermatology.. 2021 October 12 Epub 10/12/2021.

Multi-ethnic genome-wide and HLA association study of total serum IgE.

Daya M, Cox C, Acevedo N, Boorgula MP, Campbell M, Chavan S, Cho MH, David GL, Kachroo P, Lasky-Su J, Li X, McHugh CP, Qiao D, Rafaels N, Beck LA, Bleecker ER, Caraballo L, Cupples AL, Figueiredo CA, Gallo RL, Hanifin J, Hansel NN, Hata TR, Hersh CP, Knight-Madden J, Leung DYM, Guttman-Yassky E, Meyers DA, O'Connor G, Ober C, Ong PY, Ortega VE, Paller AS, Putcha N, Reed RM, Schneider LC, Silverman EK, Slifka MK, Spergel JM, Vasan RS, Viaud-Martinez KA, Watson H, Weiss ST, , Ruczinski I, Beaty TH, Mathias RA, Barnes KC

The Journal of allergy and clinical immunology.. 2021 September 15 Epub 09/15/2021.

Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors.

Arehart CH, Daya M, Campbell M, Boorgula MP, Rafaels N, Chavan S, David G, Hanifin J, Slifka MK, Gallo RL, Hata T, Schneider LC, Paller AS, Ong PY, Spergel JM, Guttman-Yassky E, Leung DYM, Beck LA, Gignoux CR, Mathias RA, Barnes KC

The Journal of allergy and clinical immunology.. 2021 June 7 Epub 06/07/2021.

Characterization of Human Keratinocyte Cell Lines for Barrier Studies.

Moran MC, Pandya RP, Leffler KA, Yoshida T, Beck LA, Brewer MG

JID innovations : skin science from molecules to population health.. 2021 June 1 (2):100018. Epub 04/28/2021.

Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial.

Siegfried EC, Bieber T, Simpson EL, Paller AS, Beck LA, Boguniewicz M, Schneider LC, Khokhar FA, Chen Z, Prescilla R, Mina-Osorio P, Bansal A

American journal of clinical dermatology.. 2021 March 3 Epub 03/03/2021.

Development of digital measures for nighttime scratch and sleep using wrist-worn wearable devices.

Mahadevan N, Christakis Y, Di J, Bruno J, Zhang Y, Dorsey ER, Pigeon WR, Beck LA, Thomas K, Liu Y, Wicker M, Brooks C, Kabiri NS, Bhangu J, Northcott C, Patel S

NPJ digital medicine.. 2021 March 34 (1):42. Epub 03/03/2021.

Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study.

Beck LA, Thaçi D, Deleuran M, de Bruin-Weller M, Chen Z, Khokhar FA, Zhang M, Ozturk ZE, Shumel B

The Journal of dermatological treatment.. 2021 February 8 :1-9. Epub 02/08/2021.

Whole genome sequencing identifies novel genetic mutations in patients with eczema herpeticum.

Bin L, Malley C, Taylor P, PreethiBoorgula M, Chavan S, Daya M, Mathias M, Shankar G, Rafaels N, Vergara C, Potee J, Campbell M, Hanifin JM, Simpson E, Schneider LC, Gallo RL, Hata T, Paller AS, De Benedetto A, Beck LA, Ong PY, Guttman-Yassky E, Richers B, Baraghoshi D, Ruczinski I, Barnes K, Leung DYM, Mathias RA

Allergy.. 2021 February 6 Epub 02/06/2021.

Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis.

Boguniewicz M, Beck LA, Sher L, Guttman-Yassky E, Thaçi D, Blauvelt A, Worm M, Corren J, Soong W, Lio P, Rossi AB, Lu Y, Chao J, Eckert L, Gadkari A, Hultsch T, Ruddy M, Mannent LP, Graham NMH, Pirozzi G, Chen Z, Ardeleanu M

The journal of allergy and clinical immunology. In practice.. 2021 January 13 Epub 01/13/2021.

Sleep Disturbances and Atopic Dermatitis: Relationships, Methods for Assessment, and Therapies.

Bawany F, Northcott CA, Beck LA, Pigeon WR

The journal of allergy and clinical immunology. In practice.. 2020 December 12 Epub 12/12/2020.

Dupilumab: One therapy to treat multiple atopic diseases.

Bawany F, Franco AI, Beck LA

JAAD case reports.. 2020 November 6 (11):1150-1152. Epub 09/09/2020.

Dupilumab Significantly Improves Sleep Outcomes in Adult Patients with Atopic Dermatitis: Results from Five Randomized Clinical Trials.

Beck LA, Silverberg JI, Simpson EL, Yosipovitch G, Eckert L, Guillemin I, Chen Z, Ardeleanu M, Plaum S, Graham N, Ruddy M, Pirozzi G, Gadkari A

Journal of the European Academy of Dermatology and Venereology : JEADV.. 2020 August 12 Epub 08/12/2020.

Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial.

Paller AS, Siegfried EC, Thaçi D, Wollenberg A, Cork MJ, Arkwright PD, Gooderham M, Beck LA, Boguniewicz M, Sher L, Weisman J, O'Malley JT, Patel N, Hardin M, Graham NMH, Ruddy M, Sun X, Davis JD, Kamal MA, Khokhar FA, Weinreich DM, Yancopoulos GD, Beazley B, Bansal A, Shumel B

Journal of the American Academy of Dermatology.. 2020 June 20 Epub 06/20/2020.

Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.

Beck LA, Thaçi D, Deleuran M, Blauvelt A, Bissonnette R, de Bruin-Weller M, Hide M, Sher L, Hussain I, Chen Z, Khokhar FA, Beazley B, Ruddy M, Patel N, Graham NMH, Ardeleanu M, Shumel B

American journal of clinical dermatology.. 2020 June 17 Epub 06/17/2020.

Assessing the need for routine safety testing for patients being treated with dupilumab for moderate-to-severe atopic dermatitis.

Wollenberg A, Beck LA, Blauvelt A, Simpson EL, Chen Z, Chen Q, Shumel B, Khokhar FA, Hultsch T, Rizova E, Rossi AB, Graham NMH, Pirozzi G, Lu Y, Ardeleanu M

The British journal of dermatology.. 2020 June 182 (6):e186-e209. Epub 1900 01 01.

A Spectrum of Skin Disease: How Staphylococcus aureus Colonization, Barrier Dysfunction, and Cytokines Shape the Skin.

Moran MC, Beck LA, Richardson CT

The Journal of investigative dermatology.. 2020 May 140 (5):941-944. Epub 1900 01 01.

The validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.

Simpson E, Bissonnette R, Eichenfield LF, Guttman E, King B, Silverberg JI, Beck LA, Bieber T, Reich K, Kabashima K, Seyger M, Siegfried E, Stingl G, Feldman SR, Menter A, van de Kerkhof P, Yosipovitch G, Paul C, Martel P, Dubost-Brama A, Armstrong J, Chavda R, Frey S, Joubert Y, Milutinovic M, Parneix A, Teixeira HD, Lin CY, Sun L, Klekotka P, Nickoloff B, Dutronc Y, Mallbris L, Janes JM, DeLozier AM, Nunes F, Paller AS

Journal of the American Academy of Dermatology.. 2020 April 25 Epub 04/25/2020.

On the cause and consequences of IgE to galactose-?-1,3-galactose: A report from the National Institute of Allergy and Infectious Diseases Workshop on Understanding IgE-Mediated Mammalian Meat Allergy.

Platts-Mills TAE, Commins SP, Biedermann T, van Hage M, Levin M, Beck LA, Diuk-Wasser M, Jappe U, Apostolovic D, Minnicozzi M, Plaut M, Wilson JM

The Journal of allergy and clinical immunology.. 2020 April 145 (4):1061-1071. Epub 02/10/2020.

Improvement in a patient with hypereosinophilic syndrome after initiation of dupilumab treatment.

Wieser JK, Kuehn GJ, Prezzano JC, Cusick EH, Stiegler JD, Scott GA, Liesveld JL, Beck LA

JAAD case reports.. 2020 April 6 (4):292-295. Epub 03/25/2020.

Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial.

Guttman-Yassky E, Thaçi D, Pangan AL, Hong HC, Papp KA, Reich K, Beck LA, Mohamed MF, Othman AA, Anderson JK, Gu Y, Teixeira HD, Silverberg JI

The Journal of allergy and clinical immunology.. 2020 March 145 (3):877-884. Epub 11/29/2019.

Halting the March: Primary Prevention of Atopic Dermatitis and Food Allergies.

Bawany F, Beck LA, Järvinen KM

The journal of allergy and clinical immunology. In practice.. 2020 March 8 (3):860-875. Epub 1900 01 01.

Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials.

Simpson EL, Lacour JP, Spelman L, Galimberti R, Eichenfield LF, Bissonnette R, King BA, Thyssen JP, Silverberg JI, Bieber T, Kabashima K, Tsunemi Y, Costanzo A, Guttman-Yassky E, Beck LA, Janes JM, DeLozier AM, Gamalo M, Brinker DR, Cardillo T, Nunes FP, Paller AS, Wollenberg A, Reich K

The British journal of dermatology.. 2020 January 5 Epub 01/05/2020.

Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis: A Randomized Clinical Trial.

Worm M, Simpson EL, Thaçi D, Bissonnette R, Lacour JP, Beissert S, Kawashima M, Ferrándiz C, Smith CH, Beck LA, Chan KC, Chen Z, Akinlade B, Hultsch T, Staudinger H, Gadkari A, Eckert L, Davis JD, Rajadhyaksha M, Graham NMH, Pirozzi G, Stahl N, Yancopoulos GD, Ardeleanu M

JAMA dermatology.. 2019 December 26 Epub 12/26/2019.

Staphylococcal Virulence Factors on the Skin of Atopic Dermatitis Patients.

Moran MC, Cahill MP, Brewer MG, Yoshida T, Knowlden S, Perez-Nazario N, Schlievert PM, Beck LA

mSphere.. 2019 December 114 (6)Epub 12/11/2019.

Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial.

Simpson EL, Paller AS, Siegfried EC, Boguniewicz M, Sher L, Gooderham MJ, Beck LA, Guttman-Yassky E, Pariser D, Blauvelt A, Weisman J, Lockshin B, Hultsch T, Zhang Q, Kamal MA, Davis JD, Akinlade B, Staudinger H, Hamilton JD, Graham NMH, Pirozzi G, Gadkari A, Eckert L, Stahl N, Yancopoulos GD, Ruddy M, Bansal A

JAMA dermatology.. 2019 November 6 Epub 11/06/2019.

The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group.

Alexander H, Paller AS, Traidl-Hoffmann C, Beck LA, De Benedetto A, Dhar S, Girolomoni G, Irvine AD, Spuls P, Su J, Thyssen JP, Vestergaard C, Werfel T, Wollenberg A, Deleuran M, Flohr C

The British journal of dermatology.. 2019 November 1 Epub 11/01/2019.

Using Language That Reflects Who Is the Center of Our Care.

Matson CC, Beck LA, Rajasekaran SK

Academic medicine : journal of the Association of American Medical Colleges.. 2019 September 94 (9):1400. Epub 1900 01 01.

Replicated methylation changes associated with eczema herpeticum and allergic response.

Boorgula MP, Taub MA, Rafaels N, Daya M, Campbell M, Chavan S, Shetty A, Cheadle C, Barkataki S, Fan J, David G, Beaty TH, Ruczinski I, Hanifin J, Schneider LC, Gallo RL, Paller AS, Beck LA, Leung DY, Mathias RA, Barnes KC

Clinical epigenetics.. 2019 August 2311 (1):122. Epub 08/23/2019.

Antagonistic Effects of IL-4 on IL-17A-Mediated Enhancement of Epidermal Tight Junction Function.

Brewer MG, Yoshida T, Kuo FI, Fridy S, Beck LA, De Benedetto A

International journal of molecular sciences.. 2019 August 2120 (17)Epub 08/21/2019.

Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS).

Wollenberg A, Beck LA, Blauvelt A, Simpson EL, Chen Z, Chen Q, Shumel B, Khokhar FA, Hultsch T, Rizova E, Rossi AB, Graham NMH, Pirozzi G, Lu Y, Ardeleanu M

The British journal of dermatology.. 2019 August 13 Epub 08/13/2019.

Peptides Derived from the Tight Junction Protein, Claudin-1, Disrupt Skin Barrier and Promote Responsiveness to an Epicutaneous Vaccine.

Brewer MG, Anderson EA, Pandya RP, De Benedetto A, Yoshida T, Hilimire TA, Martinez-Sobrido L, Beck LA, Miller BL

The Journal of investigative dermatology.. 2019 August 2 Epub 08/02/2019.

Dupilumab shows long-term safety and efficacy in moderate-to-severe atopic dermatitis patients enrolled in a phase 3 open-label extension study.

Deleuran M, Thaçi D, Beck LA, de Bruin-Weller M, Blauvelt A, Forman S, Bissonnette R, Reich K, Soong W, Hussain I, Foley P, Hide M, Bouaziz JD, Gelfand JM, Sher L, Schuttelaar MLA, Wang C, Chen Z, Akinlade B, Gadkari A, Eckert L, Davis JD, Rajadhyaksha M, Staudinger H, Graham NMH, Pirozzi G, Ardeleanu M

Journal of the American Academy of Dermatology.. 2019 July 30 Epub 07/30/2019.

Remarkable response to dupilumab in a 5-year-old patient with severe, recalcitrant atopic dermatitis.

Johnson BB, Beck LA, Mustafa SS

JAAD case reports.. 2019 July 5 (7):605-608. Epub 07/11/2019.

Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis.

Eichenfield LF, Bieber T, Beck LA, Simpson EL, Thaçi D, de Bruin-Weller M, Deleuran M, Silverberg JI, Ferrandiz C, Fölster-Holst R, Chen Z, Graham NMH, Pirozzi G, Akinlade B, Yancopoulos GD, Ardeleanu M

American journal of clinical dermatology.. 2019 June 20 (3):443-456. Epub 1900 01 01.

Electrophysiological Guidance of Epidural Electrode Array Implantation over the Human Lumbosacral Spinal Cord to Enable Motor Function after Chronic Paralysis.

Calvert JS, Grahn PJ, Strommen JA, Lavrov IA, Beck LA, Gill ML, Linde MB, Brown DA, Van Straaten MG, Veith DD, Lopez C, Sayenko DG, Gerasimenko YP, Edgerton VR, Zhao KD, Lee KH

Journal of neurotrauma.. 2019 May 136 (9):1451-1460. Epub 12/15/2018.

Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice

Lebwohl M, Alexis AF, Beck LA, Block JK, Eichenfield LF, Fonacier L, Guttman-Yassky E, Paller AS, Pariser D, Silverberg JI, Boguniewicz M

Journal of drugs in dermatology : JDD.. 2019 February 118 (2):122-129. Epub 1900 01 01.

Report from the National Institute of Allergy and Infectious Diseases Workshop on "Atopic Dermatitis and the Atopic March: Mechanisms and Interventions".

Davidson WF, Leung DYM, Beck LA, Berin CM, Boguniewicz M, Busse WW, Chatila TA, Geha RS, Gern JE, Guttman-Yassky E, Irvine AD, Kim BS, Kong HH, Lack G, Nadeau KC, Schwaninger J, Simpson A, Simpson EL, Spergel JM, Togias A, Wahn U, Wood RA, Woodfolk JA, Ziegler SF, Plaut M

The Journal of allergy and clinical immunology.. 2019 January 9 Epub 01/09/2019.

Treatment-resistant atopic dermatitis: challenges and solutions.

Johnson BB, Franco AI, Beck LA, Prezzano JC

Clinical, cosmetic and investigational dermatology.. 2019 12 :181-192. Epub 03/21/2019.

Publisher Correction: Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia.

Gill ML, Grahn PJ, Calvert JS, Linde MB, Lavrov IA, Strommen JA, Beck LA, Sayenko DG, Van Straaten MG, Drubach DI, Veith DD, Thoreson AR, Lopez C, Gerasimenko YP, Edgerton VR, Lee KH, Zhao KD

Nature medicine.. 2018 December 24 (12):1942. Epub 1900 01 01.

Building an oncology community of practice to improve cancer care.

Fingrut W, Beck LA, Lo D

Current oncology.. 2018 December 25 (6):371-377. Epub 12/01/2018.

Oncology communities of practice: insights from a qualitative analysis.

Fingrut W, Beck LA, Lo D

Current oncology.. 2018 December 25 (6):378-383. Epub 12/01/2018.

Severe atopic dermatitis: Therapeutic update.

Kwon CW, Beck LA

Allergy and asthma proceedings :. 2018 November 139 (6):411-419. Epub 1900 01 01.

Functional outcomes in patients with co-occurring traumatic brain injury and spinal cord injury from an inpatient rehabilitation facility's perspective.

Garlanger KL, Beck LA, Cheville AL

The journal of spinal cord medicine.. 2018 November 41 (6):718-730. Epub 05/01/2018.

Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia.

Gill ML, Grahn PJ, Calvert JS, Linde MB, Lavrov IA, Strommen JA, Beck LA, Sayenko DG, Van Straaten MG, Drubach DI, Veith DD, Thoreson AR, Lopez C, Gerasimenko YP, Edgerton VR, Lee KH, Zhao KD

Nature medicine.. 2018 November 24 (11):1677-1682. Epub 09/24/2018.

Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast.

An Y, Adams JR, Hollern DP, Zhao A, Chang SG, Gams MS, Chung PED, He X, Jangra R, Shah JS, Yang J, Beck LA, Raghuram N, Kozma KJ, Loch AJ, Wang W, Fan C, Done SJ, Zacksenhaus E, Guidos CJ, Perou CM, Egan SE

Cell reports.. 2018 October 1625 (3):702-714.e6. Epub 1900 01 01.

Patients with Atopic Dermatitis Colonized with Staphylococcus aureus Have a Distinct Phenotype and Endotype.

Simpson EL, Villarreal M, Jepson B, Rafaels N, David G, Hanifin J, Taylor P, Boguniewicz M, Yoshida T, De Benedetto A, Barnes KC, Leung DYM, Beck LA

The Journal of investigative dermatology.. 2018 October 138 (10):2224-2233. Epub 03/28/2018.

Image gallery: Hairy-cell leukaemia presenting with Sweet syndrome.

Shah PR, Scott G, Beck LA

The British journal of dermatology.. 2018 September 8 Epub 09/08/2018.

Title: Quantifying the change of spasticity after intrathecal baclofen administration: A descriptive retrospective analysis.

Pittelkow TP, Bendel MA, Lueders DR, Beck LA, Pingree MJ, Hoelzer BC

Clinical neurology and neurosurgery.. 2018 August 171 :163-167. Epub 06/10/2018.

Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States.

Ke X, Kavati A, Wertz D, Huang Q, Wang L, Willey VJ, Stephenson JJ, Ortiz B, Paknis B, Bernstein JA, Beck LA

Journal of managed care & specialty pharmacy.. 2018 July 24 (7):598-606. Epub 1900 01 01.

Atopic dermatitis.

Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD

Nature reviews. Disease primers.. 2018 June 214 (1):1. Epub 06/21/2018.

Adult attachment and physical health.

Pietromonaco PR, Beck LA

Current opinion in psychology.. 2018 April 1625 :115-120. Epub 04/16/2018.

Necrotizing Sweet Syndrome of the Upper Extremity After Elective Hand Surgery.

Lipof JS, Beck LA, Reddy SC, Southgate RD, Carney-Young K, Hammert WC

The Journal of hand surgery.. 2018 April 43 (4):389.e1-389.e6. Epub 09/19/2017.

Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticaria.

Wang L, Ke X, Kavati A, Wertz D, Huang Q, Willey VJ, Stephenson JJ, Ortiz B, Paknis B, Bernstein JA, Beck LA

Current medical research and opinion.. 2018 January 34 (1):35-39. Epub 11/10/2017.

Parental decisions for adolescent patients: ethical considerations of information withholding.

Soh JM, Mercurio MG, Beck LA

Journal of the American Academy of Dermatology.. 2017 December 29 Epub 12/29/2017.

Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States.

Ke X, Kavati A, Wertz D, Huang Q, Wang L, Willey VJ, Stephenson JJ, Ortiz B, Paknis B, Bernstein JA, Beck LA

Journal of managed care & specialty pharmacy.. 2017 December 19 :1-11. Epub 12/19/2017.

Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in atopic dermatitis.

Li S, Villarreal M, Stewart S, Choi J, Indra G, Babineau DC, Philpot C, David G, Yoshida T, Boguniewicz M, Hanifin J, Beck LA, Leung D, Simpson E, Indra AK

The British journal of dermatology.. 2017 October 177 (4):e125-e127. Epub 09/05/2017.

Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria.

Finlay AY, Kaplan AP, Beck LA, Antonova EN, Balp MM, Zazzali J, Khalil S, Maurer M

Journal of the European Academy of Dermatology and Venereology : JEADV.. 2017 October 31 (10):1715-1721. Epub 07/19/2017.

High Expectations.

Beck LA

The journal of spinal cord medicine.. 2017 September 40 (5):500. Epub 07/19/2017.

Bullous pemphigoid associated with nivolumab, a programmed cell death 1 protein inhibitor.

Kwon CW, Land AS, Smoller BR, Scott G, Beck LA, Mercurio MG

Journal of the European Academy of Dermatology and Venereology : JEADV.. 2017 August 31 (8):e349-e350. Epub 03/03/2017.

Long-Term Treatment of Atopic Dermatitis.

Prezzano JC, Beck LA

Dermatologic clinics.. 2017 July 35 (3):335-349. Epub 05/06/2017.

A clinical trial of intradermal and intramuscular seasonal influenza vaccination in patients with atopic dermatitis.

Leung DY, Jepson B, Beck LA, Hanifin JM, Schneider LC, Paller AS, Monti K, David G, Canniff J, Lorenzo MG, Weinberg A

The Journal of allergy and clinical immunology.. 2017 May 139 (5):1575-1582.e8. Epub 02/13/2017.

Addendum Guidelines for the Prevention of Peanut Allergy in the United States: Summary of the National Institute of Allergy and Infectious Diseases-Sponsored Expert Panel.

Togias A, Cooper SF, Acebal ML, Assa'ad A, Baker JR, Beck LA, Block J, Byrd-Bredbenner C, Chan ES, Eichenfield LF, Fleischer DM, Fuchs GJ, Furuta GT, Greenhawt MJ, Gupta RS, Habich M, Jones SM, Keaton K, Muraro A, Plaut M, Rosenwasser LJ, Rotrosen D, Sampson HA, Schneider LC, Sicherer SH, Sidbury R, Spergel J, Stukus DR, Venter C, Boyce JA

Journal of the Academy of Nutrition and Dietetics.. 2017 May 117 (5):788-793. Epub 1900 01 01.

Enabling Task-Specific Volitional Motor Functions via Spinal Cord Neuromodulation in a Human With Paraplegia.

Grahn PJ, Lavrov IA, Sayenko DG, Van Straaten MG, Gill ML, Strommen JA, Calvert JS, Drubach DI, Beck LA, Linde MB, Thoreson AR, Lopez C, Mendez AA, Gad PN, Gerasimenko YP, Edgerton VR, Zhao KD, Lee KH

Mayo Clinic proceedings.. 2017 April 92 (4):544-554. Epub 1900 01 01.

Addendum guidelines for the prevention of peanut allergy in the United States.

Togias A, Cooper SF, Acebal ML, Assa?ad A, Baker JR, Beck LA, Block J, Byrd-Bredbenner C, Chan ES, Eichenfield LF, Fleischer DM, Fuchs GJ, Furuta GT, Greenhawt MJ, Gupta RS, Habich M, Jones SM, Keaton K, Muraro A, Plaut M, Rosenwasser LJ, Rotrosen D, Sampson HA, Schneider LC, Sicherer SH, Sidbury R, Spergel J, Stukus DR, Venter C, Boyce JA

JAAPA : official journal of the American Academy of Physician Assistants.. 2017 March 30 (3):1-5. Epub 1900 01 01.

A Review of International Recommendations for the Diagnosis and Management of Chronic Urticaria.

Beck LA, Bernstein JA, Maurer M

Acta dermato-venereologica.. 2017 February 897 (2):149-158. Epub 1900 01 01.

Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel.

Togias A, Cooper SF, Acebal ML, Assa'ad A, Baker JR, Beck LA, Block J, Byrd-Bredbenner C, Chan ES, Eichenfield LF, Fleischer DM, Fuchs GJ, Furuta GT, Greenhawt MJ, Gupta RS, Habich M, Jones SM, Keaton K, Muraro A, Plaut M, Rosenwasser LJ, Rotrosen D, Sampson HA, Schneider LC, Sicherer SH, Sidbury R, Spergel J, Stukus DR, Venter C, Boyce JA

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.. 2017 February 118 (2):166-173.e7. Epub 01/05/2017.

Addendum guidelines for the prevention of peanut allergy in the United States: Summary of the National Institute of Allergy and Infectious Diseases-sponsored expert panel.

Togias A, Cooper SF, Acebal ML, Assa'ad A, Baker JR, Beck LA, Block J, Byrd-Bredbenner C, Chan ES, Eichenfield LF, Fleischer DM, Fuchs GJ, Furuta GT, Greenhawt MJ, Gupta RS, Habich M, Jones SM, Keaton K, Muraro A, Plaut M, Rosenwasser LJ, Rotrosen D, Sampson HA, Schneider LC, Sicherer SH, Sidbury R, Spergel J, Stukus DR, Venter C, Boyce JA

Pediatric dermatology.. 2017 January 34 (1):5-12. Epub 1900 01 01.

Addendum Guidelines for the Prevention of Peanut Allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-Sponsored Expert Panel.

Togias A, Cooper SF, Acebal ML, Assa'ad A, Baker JR, Beck LA, Block J, Byrd-Bredbenner C, Chan ES, Eichenfield LF, Fleischer DM, Fuchs GJ, Furuta GT, Greenhawt MJ, Gupta RS, Habich M, Jones SM, Keaton K, Muraro A, Plaut M, Rosenwasser LJ, Rotrosen D, Sampson HA, Schneider LC, Sicherer SH, Sidbury R, Spergel J, Stukus DR, Venter C, Boyce JA

Pediatric dermatology.. 2017 January 34 (1):e1-e21. Epub 1900 01 01.

Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel.

Togias A, Cooper SF, Acebal ML, Assa'ad A, Baker JR, Beck LA, Block J, Byrd-Bredbenner C, Chan ES, Eichenfield LF, Fleischer DM, Fuchs GJ, Furuta GT, Greenhawt MJ, Gupta RS, Habich M, Jones SM, Keaton K, Muraro A, Plaut M, Rosenwasser LJ, Rotrosen D, Sampson HA, Schneider LC, Sicherer SH, Sidbury R, Spergel J, Stukus DR, Venter C, Boyce JA

The Journal of allergy and clinical immunology.. 2017 January 139 (1):29-44. Epub 1900 01 01.

Addendum Guidelines for the Prevention of Peanut Allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases-Sponsored Expert Panel.

Togias A, Cooper SF, Acebal ML, Assa'ad A, Baker JR, Beck LA, Block J, Byrd-Bredbenner C, Chan ES, Eichenfield LF, Fleischer DM, Fuchs GJ, Furuta GT, Greenhawt MJ, Gupta RS, Habich M, Jones SM, Keaton K, Muraro A, Plaut M, Rosenwasser LJ, Rotrosen D, Sampson HA, Schneider LC, Sicherer SH, Sidbury R, Spergel J, Stukus DR, Venter C, Boyce JA

Journal of pediatric nursing.. 2017 32 :91-98. Epub 1900 01 01.

Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging Therapies.

Boguniewicz M, Alexis AF, Beck LA, Block J, Eichenfield LF, Fonacier L, Guttman-Yassky E, Paller AS, Pariser D, Silverberg JI, Lebwohl M

The journal of allergy and clinical immunology. In practice.. 2017 5 (6):1519-1531. Epub 09/29/2017.

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.

Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M,

The New England journal of medicine.. 2016 December 15375 (24):2335-2348. Epub 09/30/2016.

Characterization of V. cholerae T3SS-dependent cytotoxicity in cultured intestinal epithelial cells.

Miller KA, Chaand M, Gregoire S, Yoshida T, Beck L, Ivanov AI, Dziejman M

Cellular microbiology.. 2016 December 18 (12):1857-1870. Epub 07/22/2016.

Immunologic Targets in Atopic Dermatitis and Emerging Therapies: An Update.

Wang D, Beck LA

American journal of clinical dermatology.. 2016 October 17 (5):425-443. Epub 1900 01 01.

?Np63 regulates IL-33 and IL-31 signaling in atopic dermatitis.

Rizzo JM, Oyelakin A, Min S, Smalley K, Bard J, Luo W, Nyquist J, Guttman-Yassky E, Yoshida T, De Benedetto A, Beck LA, Sinha S, Romano RA

Cell death and differentiation.. 2016 June 23 (6):1073-85. Epub 01/15/2016.

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.

Thaçi D, Simpson EL, Beck LA, Bieber T, Blauvelt A, Papp K, Soong W, Worm M, Szepietowski JC, Sofen H, Kawashima M, Wu R, Weinstein SP, Graham NM, Pirozzi G, Teper A, Sutherland ER, Mastey V, Stahl N, Yancopoulos GD, Ardeleanu M

Lancet.. 2016 January 2387 (10013):40-52. Epub 10/08/2015.

Lymphomatoid Papulosis Type D: Report of a Case in a Child and Review of the Literature.

Barrett MM, Strikwerda AM, Somers K, Beck LA, Scott GA

Pediatric dermatology.. 2016 33 (2):e52-6. Epub 01/14/2016.

Temporal and Racial Differences Associated with Atopic Dermatitis and Encoded Virulence Factors.

Merriman JA, Mueller EA, Cahill MP, Beck LA, Paller AS, Hanifin JM, Ong PY, Schneider L, Babineau DC, David G, Lockhart A, Artis K, Leung DY, Schlievert PM

mSphere.. 2016 1 (6)Epub 12/07/2016.

Targeted deep sequencing identifies rare loss-of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticum.

Gao L, Bin L, Rafaels NM, Huang L, Potee J, Ruczinski I, Beaty TH, Paller AS, Schneider LC, Gallo R, Hanifin JM, Beck LA, Geha RS, Mathias RA, Barnes KC, Leung DY

The Journal of allergy and clinical immunology.. 2015 December 136 (6):1591-1600. Epub 09/03/2015.

Histamine and Skin Barrier: Are Histamine Antagonists Useful for the Prevention or Treatment of Atopic Dermatitis?

De Benedetto A, Yoshida T, Fridy S, Park JE, Kuo IH, Beck LA

Journal of clinical medicine.. 2015 April 214 (4):741-55. Epub 04/21/2015.

Toll-like receptor 3 activation is required for normal skin barrier repair following UV damage.

Borkowski AW, Kuo IH, Bernard JJ, Yoshida T, Williams MR, Hung NJ, Yu BD, Beck LA, Gallo RL

The Journal of investigative dermatology.. 2015 February 135 (2):569-578. Epub 08/12/2014.

Epidermal tight junctions in health and disease.

Brandner JM, Zorn-Kruppa M, Yoshida T, Moll I, Beck LA, De Benedetto A

Tissue barriers.. 2015 3 (1-2):e974451. Epub 04/03/2015.

Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.

Beck LA, Thaçi D, Hamilton JD, Graham NM, Bieber T, Rocklin R, Ming JE, Ren H, Kao R, Simpson E, Ardeleanu M, Weinstein SP, Pirozzi G, Guttman-Yassky E, Suárez-Fariñas M, Hager MD, Stahl N, Yancopoulos GD, Radin AR

The New England journal of medicine.. 2014 July 10371 (2):130-9. Epub 1900 01 01.

Quantification of quantum dot murine skin penetration with UVR barrier impairment.

Mortensen LJ, Jatana S, Gelein R, Debenedetto A, de Mesy Bentley KL, Beck L, Elder A, Delouise L

Nanotoxicology.. 2013 December 7 (8):1386-98. Epub 04/17/2013.

Sustained protein kinase D activation mediates respiratory syncytial virus-induced airway barrier disruption.

Rezaee F, Desando SA, Ivanov AI, Chapman TJ, Knowlden SA, Beck LA, Georas SN

Journal of virology.. 2013 October 87 (20):11088-95. Epub 08/07/2013.

Atopic dermatitis complicated by eczema herpeticum is associated with HLA B7 and reduced interferon-?-producing CD8+ T cells.

Mathias RA, Weinberg A, Boguniewicz M, Zaccaro DJ, Armstrong B, Schneider LC, Hata TR, Hanifin JM, Beck LA, Barnes KC, Leung DY

The British journal of dermatology.. 2013 September 169 (3):700-3. Epub 1900 01 01.

Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair.

Kuo IH, Carpenter-Mendini A, Yoshida T, McGirt LY, Ivanov AI, Barnes KC, Gallo RL, Borkowski AW, Yamasaki K, Leung DY, Georas SN, De Benedetto A, Beck LA

The Journal of investigative dermatology.. 2013 April 133 (4):988-98. Epub 12/06/2012.

The cutaneous innate immune response in patients with atopic dermatitis.

Kuo IH, Yoshida T, De Benedetto A, Beck LA

The Journal of allergy and clinical immunology.. 2013 February 131 (2):266-78. Epub 1900 01 01.

Update on systemic therapies for atopic dermatitis.

Denby KS, Beck LA

Current opinion in allergy and clinical immunology.. 2012 August 12 (4):421-6. Epub 1900 01 01.

Aldo-keto reductase 1C3 is expressed in differentiated human epidermis, affects keratinocyte differentiation, and is upregulated in atopic dermatitis.

Mantel A, Carpenter-Mendini AB, Vanbuskirk JB, De Benedetto A, Beck LA, Pentland AP

The Journal of investigative dermatology.. 2012 April 132 (4):1103-10. Epub 12/15/2011.

Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum.

Gao PS, Leung DY, Rafaels NM, Boguniewicz M, Hand T, Gao L, Hata TR, Schneider LC, Hanifin JM, Beaty TH, Beck LA, Weinberg A, Barnes KC

The Journal of investigative dermatology.. 2012 March 132 (3 Pt 1):650-7. Epub 11/24/2011.

Skin barrier disruption: a requirement for allergen sensitization?

De Benedetto A, Kubo A, Beck LA

The Journal of investigative dermatology.. 2012 March 132 (3 Pt 2):949-63. Epub 01/05/2012.

Polyinosinic:polycytidylic acid induces protein kinase D-dependent disassembly of apical junctions and barrier dysfunction in airway epithelial cells.

Rezaee F, Meednu N, Emo JA, Saatian B, Chapman TJ, Naydenov NG, Debenedetto A, Beck LA, Ivanov AI, Georas SN

The Journal of allergy and clinical immunology.. 2011 December 128 (6):1216-1224.e11. Epub 10/11/2011.

The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infections.

Howell MD, Gao P, Kim BE, Lesley LJ, Streib JE, Taylor PA, Zaccaro DJ, Boguniewicz M, Beck LA, Hanifin JM, Schneider LC, Hata TR, Gallo RL, Kaplan MH, Barnes KC, Leung DY

The Journal of allergy and clinical immunology.. 2011 November 128 (5):1006-14. Epub 07/18/2011.

Fibroblast growth factor-peptide improves barrier function and proliferation in human keratinocytes after radiation.

Zhang K, Tian Y, Yin L, Zhang M, Beck LA, Zhang B, Okunieff P, Zhang L, Vidyasagar S

International journal of radiation oncology, biology, physics.. 2011 September 181 (1):248-54. Epub 04/12/2011.

Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis.

De Benedetto A, Slifka MK, Rafaels NM, Kuo IH, Georas SN, Boguniewicz M, Hata T, Schneider LC, Hanifin JM, Gallo RL, Johnson DC, Barnes KC, Leung DY, Beck LA

The Journal of allergy and clinical immunology.. 2011 July 128 (1):242-246.e5. Epub 04/13/2011.

Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-? response.

Leung DY, Gao PS, Grigoryev DN, Rafaels NM, Streib JE, Howell MD, Taylor PA, Boguniewicz M, Canniff J, Armstrong B, Zaccaro DJ, Schneider LC, Hata TR, Hanifin JM, Beck LA, Weinberg A, Barnes KC

The Journal of allergy and clinical immunology.. 2011 April 127 (4):965-73.e1-5. Epub 1900 01 01.

Tight junction defects in patients with atopic dermatitis.

De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C, Berger AE, Zhang K, Vidyasagar S, Yoshida T, Boguniewicz M, Hata T, Schneider LM, Hanifin JM, Gallo RL, Novak N, Weidinger S, Beaty TH, Leung DY, Barnes KC, Beck LA

The Journal of allergy and clinical immunology.. 2011 March 127 (3):773-86.e1-7. Epub 12/15/2010.

Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report.

Boyce JA, Assa'a A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA, Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM,

Nutrition.. 2011 February 27 (2):253-67. Epub 1900 01 01.

Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel report.

Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA, Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM

Journal of the American Academy of Dermatology.. 2011 January 64 (1):175-92. Epub 1900 01 01.

Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report.

Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA, Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM

Nutrition research.. 2011 January 31 (1):61-75. Epub 1900 01 01.

Mannan-binding lectin levels and activity are not altered in atopic dermatitis patients with a history of eczema herpeticum.

Bundy KW, McGirt LY, Bankova LG, Wollenberg A, Beck LA, De Benedetto A

Dermatology research and practice.. 2011 2011 :769890. Epub 11/10/2011.

Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report.

Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA, Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM,

The Journal of allergy and clinical immunology.. 2010 December 126 (6):1105-18. Epub 1900 01 01.

Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel.

, Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA, Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM

The Journal of allergy and clinical immunology.. 2010 December 126 (6 Suppl):S1-58. Epub 1900 01 01.

IL-17: important for host defense, autoimmunity, and allergy?

Lee FE, Georas SN, Beck LA

The Journal of investigative dermatology.. 2010 November 130 (11):2540-2. Epub 1900 01 01.

Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum.

Gao PS, Rafaels NM, Mu D, Hand T, Murray T, Boguniewicz M, Hata T, Schneider L, Hanifin JM, Gallo RL, Gao L, Beaty TH, Beck LA, Leung DY, Barnes KC

The Journal of allergy and clinical immunology.. 2010 June 125 (6):1403-1407.e4. Epub 05/13/2010.

Dangerous allergens: why some allergens are bad actors.

Georas SN, Rezaee F, Lerner L, Beck L

Current allergy and asthma reports.. 2010 March 10 (2):92-8. Epub 1900 01 01.

Cytokine modulation of atopic dermatitis filaggrin skin expression.

Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, DeBenedetto A, Schneider L, Beck LA, Barnes KC, Leung DY

The Journal of allergy and clinical immunology.. 2009 September 124 (3 Suppl 2):R7-R12. Epub 1900 01 01.

Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum.

Gao PS, Rafaels NM, Hand T, Murray T, Boguniewicz M, Hata T, Schneider L, Hanifin JM, Gallo RL, Gao L, Beaty TH, Beck LA, Barnes KC, Leung DY

The Journal of allergy and clinical immunology.. 2009 September 124 (3):507-13, 513.e1-7. Epub 1900 01 01.

Phenotype of atopic dermatitis subjects with a history of eczema herpeticum.

Beck LA, Boguniewicz M, Hata T, Schneider LC, Hanifin J, Gallo R, Paller AS, Lieff S, Reese J, Zaccaro D, Milgrom H, Barnes KC, Leung DY

The Journal of allergy and clinical immunology.. 2009 August 124 (2):260-9, 269.e1-7. Epub 06/27/2009.

Biomarkers of Th2 polarity are predictive of staphylococcal colonization in subjects with atopic dermatitis.

Warner JA, McGirt LY, Beck LA

The British journal of dermatology.. 2009 January 160 (1):183-5. Epub 10/25/2008.

Atopic dermatitis: a disease caused by innate immune defects?

De Benedetto A, Agnihothri R, McGirt LY, Bankova LG, Beck LA

The Journal of investigative dermatology.. 2009 January 129 (1):14-30. Epub 1900 01 01.

Evaluation of the effect of the specific CCR1 antagonist CP-481715 on the clinical and cellular responses observed following epicutaneous nickel challenge in human subjects.

Borregaard J, Skov L, Wang L, Ting N, Wang C, Beck LA, Sonne J, Clucas A

Contact dermatitis.. 2008 October 59 (4):212-9. Epub 1900 01 01.

Cutaneous myiasis arising in an eccrine adnexal neoplasm.

Ibrahim SF, Pryor J, Merritt RW, Scott G, Beck LA

Dermatology online journal.. 2008 June 1514 (6):6. Epub 06/15/2008.

Filaggrin expression in oral, nasal, and esophageal mucosa.

De Benedetto A, Qualia CM, Baroody FM, Beck LA

The Journal of investigative dermatology.. 2008 June 128 (6):1594-7. Epub 01/03/2008.

Pathophysiology of chronic urticaria.

Brodell LA, Beck LA, Saini SS

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.. 2008 April 100 (4):291-7; quiz 297-9, 322. Epub 1900 01 01.

Differential diagnosis of chronic urticaria.

Brodell LA, Beck LA

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.. 2008 March 100 (3):181-8; quiz 188-90, 215. Epub 1900 01 01.

IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission.

Ryan JG, de Koning HD, Beck LA, Booty MG, Kastner DL, Simon A

The Journal of allergy and clinical immunology.. 2008 January 121 (1):260-2. Epub 10/22/2007.

The effect of etanercept on the human cutaneous allergic response.

Conner E, Bochner BS, Brummet M, Beck LA

The Journal of allergy and clinical immunology.. 2008 January 121 (1):258-60. Epub 1900 01 01.

Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.

Delong LK, Culler SD, Saini SS, Beck LA, Chen SC

Archives of dermatology.. 2008 January 144 (1):35-9. Epub 1900 01 01.

Cytokine modulation of atopic dermatitis filaggrin skin expression.

Howell MD, Kim BE, Gao P, Grant AV, Boguniewicz M, Debenedetto A, Schneider L, Beck LA, Barnes KC, Leung DY

The Journal of allergy and clinical immunology.. 2007 July 120 (1):150-5. Epub 05/23/2007.

Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine.

McGirt LY, Vasagar K, Gober LM, Saini SS, Beck LA

Archives of dermatology.. 2006 October 142 (10):1337-42. Epub 1900 01 01.

Functional analysis of the chemokine receptor CCR3 on airway epithelial cells.

Beck LA, Tancowny B, Brummet ME, Asaki SY, Curry SL, Penno MB, Foster M, Bahl A, Stellato C

The Journal of immunology : official journal of the American Association of Immunologists.. 2006 September 1177 (5):3344-54. Epub 1900 01 01.

Wanted: A study with omalizumab to determine the role of IgE-mediated pathways in atopic dermatitis.

Beck LA, Saini S

Journal of the American Academy of Dermatology.. 2006 September 55 (3):540-1; author reply 541-2. Epub 1900 01 01.

Increased expression of Th2-associated chemokines in bullous pemphigoid disease. Role of eosinophils in the production and release of these chemokines.

Gounni Abdelilah S, Wellemans V, Agouli M, Guenounou M, Hamid Q, Beck LA, Lamkhioued B

Clinical immunology : the official journal of the Clinical Immunology Society.. 2006 August 120 (2):220-31. Epub 06/16/2006.

Polymorphisms in the novel gene acyloxyacyl hydroxylase (AOAH) are associated with asthma and associated phenotypes.

Barnes KC, Grant A, Gao P, Baltadjieva D, Berg T, Chi P, Zhang S, Zambelli-Weiner A, Ehrlich E, Zardkoohi O, Brummet ME, Stockton M, Watkins T, Gao L, Gittens M, Wills-Karp M, Cheadle C, Beck LA, Beaty TH, Becker KG, Garcia JG, Mathias RA

The Journal of allergy and clinical immunology.. 2006 July 118 (1):70-7. Epub 05/30/2006.

Innate immune defects in atopic dermatitis.

McGirt LY, Beck LA

The Journal of allergy and clinical immunology.. 2006 July 118 (1):202-8. Epub 06/06/2006.

Emerging therapeutic options for atopic dermatitis: beyond TIMs.

Conner ER, Beck LA

Current allergy and asthma reports.. 2006 July 6 (4):275-81. Epub 1900 01 01.

Chemokines: key players in innate and adaptive immunity.

Esche C, Stellato C, Beck LA

The Journal of investigative dermatology.. 2005 October 125 (4):615-28. Epub 1900 01 01.

The efficacy and safety of tacrolimus ointment: a clinical review.

Beck LA

Journal of the American Academy of Dermatology.. 2005 August 53 (2 Suppl 2):S165-70. Epub 1900 01 01.

Activation of airway epithelial cells by toll-like receptor agonists.

Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP

American journal of respiratory cell and molecular biology.. 2004 September 31 (3):358-64. Epub 06/10/2004.

Omalizumab-induced reductions in mast cell Fce psilon RI expression and function.

Beck LA, Marcotte GV, MacGlashan D, Togias A, Saini S

The Journal of allergy and clinical immunology.. 2004 September 114 (3):527-30. Epub 1900 01 01.

Keratinocytes in atopic dermatitis: inflammatory signals.

Esche C, de Benedetto A, Beck LA

Current allergy and asthma reports.. 2004 July 4 (4):276-84. Epub 1900 01 01.

Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.

Garrett JK, Jameson SC, Thomson B, Collins MH, Wagoner LE, Freese DK, Beck LA, Boyce JA, Filipovich AH, Villanueva JM, Sutton SA, Assa'ad AH, Rothenberg ME

The Journal of allergy and clinical immunology.. 2004 January 113 (1):115-9. Epub 12/12/2003.

Atopic dermatitis and asthma: parallels in the evolution of treatment.

Eichenfield LF, Hanifin JM, Beck LA, Lemanske RF, Sampson HA, Weiss ST, Leung DY

Pediatrics.. 2003 March 111 (3):608-16. Epub 1900 01 01.

What is eotaxin doing in the pleura? Insights into innate immunity from pleural mesothelial cells.

Georas SN, Beck LA, Stellato C

American journal of respiratory cell and molecular biology.. 2002 April 26 (4):384-7. Epub 1900 01 01.

Expression of the C-C chemokine receptor CCR3 in human airway epithelial cells.

Stellato C, Brummet ME, Plitt JR, Shahabuddin S, Baroody FM, Liu MC, Ponath PD, Beck LA

The Journal of immunology : official journal of the American Association of Immunologists.. 2001 February 1166 (3):1457-61. Epub 1900 01 01.

Human eosinophils constitutively express nuclear factor of activated T cells p and c.

Seminario MC, Guo J, Bochner BS, Beck LA, Georas SN

The Journal of allergy and clinical immunology.. 2001 January 107 (1):143-52. Epub 1900 01 01.

Allergen sensitization through the skin induces systemic allergic responses.

Beck LA, Leung DY

The Journal of allergy and clinical immunology.. 2000 November 106 (5 Suppl):S258-63. Epub 1900 01 01.

Eotaxin and RANTES expression by the dermal endothelium is associated with eosinophil infiltration after ivermectin treatment of onchocerciasis.

Cooper PJ, Beck LA, Espinel I, Deyampert NM, Hartnell A, Jose PJ, Paredes W, Guderian RH, Nutman TB

Clinical immunology : the official journal of the Clinical Immunology Society.. 2000 April 95 (1 Pt 1):51-61. Epub 1900 01 01.

Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes.

Lee SC, Brummet ME, Shahabuddin S, Woodworth TG, Georas SN, Leiferman KM, Gilman SC, Stellato C, Gladue RP, Schleimer RP, Beck LA

The Journal of immunology : official journal of the American Association of Immunologists.. 2000 March 15164 (6):3392-401. Epub 1900 01 01.

Glucocorticoids inhibit calcium- and calcineurin-dependent activation of the human IL-4 promoter.

Chen R, Burke TF, Cumberland JE, Brummet M, Beck LA, Casolaro V, Georas SN

The Journal of immunology : official journal of the American Association of Immunologists.. 2000 January 15164 (2):825-32. Epub 1900 01 01.

Expression of eosinophil-specific chemokines by human epithelial cells.

Stellato C, Beck LA

Chemical immunology.. 2000 76 :156-76. Epub 1900 01 01.

Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide.

Stellato C, Matsukura S, Fal A, White J, Beck LA, Proud D, Schleimer RP

The Journal of immunology : official journal of the American Association of Immunologists.. 1999 November 15163 (10):5624-32. Epub 1900 01 01.

Chemokines and allergic disease.

Nickel R, Beck LA, Stellato C, Schleimer RP

The Journal of allergy and clinical immunology.. 1999 October 104 (4 Pt 1):723-42. Epub 1900 01 01.

CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils.

Matsumoto K, Appiah-Pippim J, Schleimer RP, Bickel CA, Beck LA, Bochner BS

American journal of respiratory cell and molecular biology.. 1998 June 18 (6):860-6. Epub 1900 01 01.

Eosinophilia and multiple erythematous indurated plaques. Idiopathic hypereosinophilic syndrome (IHS).

DeYampert NM, Beck LA

Archives of dermatology.. 1997 December 133 (12):1581, 1584. Epub 1900 01 01.

Cutaneous injection of RANTES causes eosinophil recruitment: comparison of nonallergic and allergic human subjects.

Beck LA, Dalke S, Leiferman KM, Bickel CA, Hamilton R, Rosen H, Bochner BS, Schleimer RP

The Journal of immunology : official journal of the American Association of Immunologists.. 1997 September 15159 (6):2962-72. Epub 1900 01 01.

Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer.

Simons JW, Jaffee EM, Weber CE, Levitsky HI, Nelson WG, Carducci MA, Lazenby AJ, Cohen LK, Finn CC, Clift SM, Hauda KM, Beck LA, Leiferman KM, Owens AH, Piantadosi S, Dranoff G, Mulligan RC, Pardoll DM, Marshall FF

Cancer research.. 1997 April 1557 (8):1537-46. Epub 1900 01 01.

Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps.

Beck LA, Stellato C, Beall LD, Schall TJ, Leopold D, Bickel CA, Baroody F, Bochner BS, Schleimer RP

The Journal of allergy and clinical immunology.. 1996 October 98 (4):766-80. Epub 1900 01 01.

Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions.

Schwiebert LM, Beck LA, Stellato C, Bickel CA, Bochner BS, Schleimer RP, Schwiebert LA

The Journal of allergy and clinical immunology.. 1996 January 97 (1 Pt 2):143-52. Epub 1900 01 01.

Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids.

Stellato C, Beck LA, Gorgone GA, Proud D, Schall TJ, Ono SJ, Lichtenstein LM, Schleimer RP

The Journal of immunology : official journal of the American Association of Immunologists.. 1995 July 1155 (1):410-8. Epub 1900 01 01.

Merkel Cell Tumor

Beck LA, Herzberg AJ, White PF, Burton CS,.

Cutis. 1989; 44: 295-99.

Books

Allergy Frontiers: Epigenetics to Future Perspectives (2008)

Chapter: Update on the Managment of Atopic Dermatitis

Authors: Ibrahim SF, DeBenedetto A, Beck LA

Publisher: Springer, Tokyo, Japan 2008

Dermatology in General Medicine (2007)

Chapter: Regulation of the Production and Activation of Eosinophils and Neutrophils

Authors: Beck LA, Loveless J, Holland S

Publisher: McGraw-Hill Co., New York 2007

Current Therapy in Allergy, Immunology and Rheumatology (2004)

Chapter: Dermatitis

Authors: Beck LA

Publisher: Mosby Yearbook Inc., St. Louis 2004

Dermatology In General Medicine (2004)

Chapter: Regulation of the Production and Activation of Eosinophils

Authors: Rencic A, Beck LA

Publisher: Mc-Graw-Hill Co., New York 2004

Human Eosinophils: Biological and Clinical Aspects (2000)

Chapter: Expression of eosinophil-specific chemokines by human epithelial cells

Authors: Stellato C., Beck LA

Publisher: Basel, Karger 2000

Inflammatory Processes: Molecular Mechanisms and Therapeutic Opportunities (2000)

Chapter: The role of chemokines in allergic diseases of the airways

Authors: Beck LA, Stellato C, Shahabuddin S, Nickel R, Schleimer RP

Publisher: Basel: Birkhauser Verlag 2000

Allergic Skin Diseases: Causes and Treatment (2000)

Chapter: Adhesion Molecules and Their Role in Allergic Skin Diseases

Authors: Bochner BS, Beck LA

Publisher: Mosby Yearbook Inc., St. Louis 2000

Cutaneous Medicine: Cutaneous Manifestations of Systemic Disease (1999)

Chapter: Urticaria

Authors: Beck LA, Provost TP

Publisher: BC Decker, Inc, Hamilton, Ontario 1999

Cutaneous Medicine: Cutaneous Manifestations of Systemic Disease (1999)

Chapter: Mastocytosis

Authors: Beck LA, Provost TP

Publisher: BC Decker Inc., Hamilton, Ontario 1999

Adhesion Molecules in Allergic Disease (1997)

Chapter: Expression of cell adhesion molecules in eosinophilic disorders of the skin and nose

Authors: Beck L, Georas SN

Publisher: Marcel Dekker, Inc., New York 1997

Current Opinion in Dermatology (1997)

Chapter: The role of food additives in urticaria

Authors: Beck L

Publisher: Rapid Science Publishers, Philadelphia, PA 1997

Topical glucocorticoids in asthma: mechanisms and clinical actions (1997)

Chapter: Inhibition of inflammatory cell recruitment by glucocorticoids: cytokines as primary targets

Authors: Schleimer RP, Beck L, Schwiebert L, Stellato C, Bochner BS

Publisher: Marcel Dekker Inc., New York 1997

Cutaneous Allergy for the Clinician (1996)

Chapter: The skin as an immune organ

Authors: Beck LA, Charlesworth EN

Publisher: Mosby, Massachusetts 1996

Textbook of Internal Medicine (1994)

Chapter: Psoriasis

Authors: Morison W, Beck LA

Publisher: Mosby, St. Louis 1994

Textbook of Internal Medicine (1994)

Chapter: Dermatological Manifestations of Gastrointestinal Diseases

Authors: Simmons-O'Brien E, Beck LA

Publisher: Mosby, St. Louis 1994

Ratings & Reviews

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.